Live from ClinicalTrials.gov + Open Targets, fetched 2026-11-12 09:06 UTC. Every row links to its source record.
Postmortem · what the sponsor and named sources said, kept apart from what merely happened at the same time
Montelukast for Patients With Obstructive Sleep Apnea Syndrome
NCT03545997 · University Hospital, Grenoble · PHASE3 · terminated · last registry update 2021-02-17 · Decision brief
No research has been run for this trial yet, so only the registry's own reason and the timeline are shown.
What was said, and by whom
Stated is the sponsor's own words; Reported is a named third party. The category is our label from a fixed list; the quote is the evidence.
| Kind | Quote | Our category | Source |
|---|---|---|---|
| Stated | “lack of recruitment” | – | Registry record, University Hospital, Grenoble |
Also happening at the time. Not shown to be a cause.
Registry events on other trials of drugs against CYSLTR1 within 12 months either side of this trial's last update, live from ClinicalTrials.gov. Nothing here was stated as a reason.
- 2022-02-16Also stopped (withdrawn): Organon and Co, MF/F Metered Dose Inhaler (MDI) 25/5 mcg + MF/F MDI 50/5 mcg (NCT01615874)
- 2022-02-14Also stopped (withdrawn): Organon and Co, Montelukast sodium + Placebo to montelukast (NCT00540839)
- 2022-01-04Results posted on the registry: GlaxoSmithKline, Fluticasone furoate + Placebo (NCT02889809)
- 2021-10-20Also stopped (terminated): Maisonneuve-Rosemont Hospital, Prednisone + Azithromycin (NCT01432080)
- 2021-05-13Phase 3 first posted: Susanna Naggie, MD, Ivermectin + Fluvoxamine (NCT04885530)
- 2021-05-04Phase 3 first posted: King Abdullah International Medical Research Center, Leukotriene Receptor Antagonist (NCT04871828)
- 2021-01-05Phase 3 first posted: Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina, Montelukast (NCT04695704)
- 2020-12-17Phase 3 first posted: Phramongkutklao College of Medicine and Hospital, Montelukast + Placebo (NCT04673422)
- 2020-10-30Results posted on the registry: Children's Mercy Hospital Kansas City, Montelukast + 5 mg Montelukast (NCT01458418)
- 2020-10-30Also stopped (terminated): Children's Mercy Hospital Kansas City, Montelukast + 5 mg Montelukast (NCT01458418)
- 2020-08-28Results posted on the registry: Symphogen A/S, Sym013 (NCT02906670)
- 2020-08-28Also stopped (terminated): Symphogen A/S, Sym013 (NCT02906670)
- 2020-05-15Phase 3 first posted: McGill University, Montelukast 10mg (NCT04389411)
- 2020-04-17Phase 3 first posted: Great Ormond Street Hospital for Children NHS Foundation Trust, Montelukast (NCT04351698)
- 2020-03-27Phase 3 first posted: Hanmi Pharmaceutical Company Limited, HCP1102 + HGP1408 (NCT04324918)
- 2020-02-20Phase 3 first posted: Jagiellonian University, Montelukast 10mg + Standard anti-platelet treatment (NCT04277702)
What is not public
- Internal portfolio and board discussions
- Unpublished trial data and interim analyses
- Terms of any partner or licence decision